List of works - Vicente Peg

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

scientific article published on 01 December 2018

A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers.

scientific article

A major role of p95/611-CTF, a carboxy-terminal fragment of HER2, in the down-modulation of the estrogen receptor in HER2-positive breast cancers

scientific article published on 26 October 2010

Beyond molecular tumor heterogeneity: protein synthesis takes control

scientific article published on 21 February 2018

Breast metastasis from rhabdomyosarcoma of the nasal septum in a pregnant adult woman

scientific article published on 02 June 2011

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

scientific article published on 01 November 2018

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.

scientific article published on 09 July 2014

Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.

scientific article published on 9 May 2009

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.

scientific article

Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements

scientific article

Detection of sentinel lymph node in breast cancer recurrence may change adjuvant treatment decision in patients with breast cancer recurrence and previous axillary surgery

scientific article published on 13 April 2014

Different Prognostic Implications of Residual Disease After Neoadjuvant Treatment: Impact of Ki 67 and Site of Response.

scientific article

Disruption of the ribosomal P complex leads to stress-induced autophagy

scientific article

Dual regulation of Myc by Abl.

scientific article published on 14 January 2013

ERRATUM: Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity

scientific article published on 11 February 2015

Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy.

scientific article

Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing

scientific article published on 31 October 2013

Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer.

scientific article

Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer

scientific article published on 22 August 2018

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

scientific article published on 22 July 2016

Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast

scientific article published on 31 January 2015

Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases.

scientific article

Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity

scientific article

High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy.

scientific article published on 15 September 2015

Integrating clinical, molecular, proteomic and histopathological data within the tissue context: tissunomics

scientific article published on 14 May 2019

Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.

scientific article published in December 2017

Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant Treatment.

scientific article

Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.

scientific article published on 28 October 2016

Intraoperative assessment of sentinel lymph nodes after neoadjuvant chemotherapy in patients with breast cancer

scientific article published on 24 September 2009

Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.

scientific article published on 11 April 2013

Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.

scientific article

Lymphatic mapping could not be impaired in the presence of breast carcinoma and coexisting small lymphocytic lymphoma

scientific article published on 21 August 2013

MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

scientific article published on 7 October 2015

Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients

scientific article published on 28 August 2014

PD-L1 testing based on SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion

scientific article published on 08 December 2020

Pathological findings in the complete trisomy 9 syndrome: three case reports and review of the literature.

scientific article published on January 2008

Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies

scientific article published on 15 June 2015

Prediction of Response to Neoadjuvant Chemotherapy Using Core Needle Biopsy Samples with the Prosigna Assay

scientific article published on 7 July 2015

Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay

scientific article published on 19 April 2013

RNA Analysis as a Tool to Determine Clinically Relevant Gene Fusions and Splice Variants.

scientific article published in April 2018

Role of total tumour load of sentinel lymph node on survival in early breast cancer patients.

scientific article

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.

scientific article

The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1

scientific article published on 13 March 2020

The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.

scientific article published on 8 July 2011

The ever-evolving role of pathologists in the management of breast cancer with neoadjuvant treatment: recommendations based on the Spanish clinical experience.

scientific article published on 9 August 2017

The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets.

scientific article

USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma

scientific article

miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

scientific article

p95HER2-T cell bispecific antibody for breast cancer treatment

scientific article published on 01 October 2018

peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas.

scientific article published on 20 July 2016

List of works by Vicente Peg

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers.

A major role of p95/611-CTF, a carboxy-terminal fragment of HER2, in the down-modulation of the estrogen receptor in HER2-positive breast cancers

Beyond molecular tumor heterogeneity: protein synthesis takes control

Breast metastasis from rhabdomyosarcoma of the nasal septum in a pregnant adult woman

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.

Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.

Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements

Detection of sentinel lymph node in breast cancer recurrence may change adjuvant treatment decision in patients with breast cancer recurrence and previous axillary surgery

Different Prognostic Implications of Residual Disease After Neoadjuvant Treatment: Impact of Ki 67 and Site of Response.

Disruption of the ribosomal P complex leads to stress-induced autophagy

Dual regulation of Myc by Abl.

ERRATUM: Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity

Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy.

Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing

Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer.

Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast

Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases.

Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity

High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy.

Integrating clinical, molecular, proteomic and histopathological data within the tissue context: tissunomics

Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.

Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant Treatment.

Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.

Intraoperative assessment of sentinel lymph nodes after neoadjuvant chemotherapy in patients with breast cancer

Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.

Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.

Lymphatic mapping could not be impaired in the presence of breast carcinoma and coexisting small lymphocytic lymphoma

MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients

PD-L1 testing based on SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion

Pathological findings in the complete trisomy 9 syndrome: three case reports and review of the literature.

Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies

Prediction of Response to Neoadjuvant Chemotherapy Using Core Needle Biopsy Samples with the Prosigna Assay

Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay

RNA Analysis as a Tool to Determine Clinically Relevant Gene Fusions and Splice Variants.

Role of total tumour load of sentinel lymph node on survival in early breast cancer patients.

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.

The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1

The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.

The ever-evolving role of pathologists in the management of breast cancer with neoadjuvant treatment: recommendations based on the Spanish clinical experience.

The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets.

USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma

miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

p95HER2-T cell bispecific antibody for breast cancer treatment

peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas.